报价延迟最少15分钟:2025/11/28 03:12 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
883.71 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
31.99/41.68
|
|
企业价值
115.70B
|
| 资产负债 |
|
每股账面净值
-14.09
|
| 现金流量 |
|
现金流量率
0.06
|
| 损益表 |
|
收益
16.91B
|
|
每股收益
2,358.47
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies. |
